News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Treating UTIs—where to from here
The discovery that the bladder isn’t sterile has opened up new avenues of treatment for urinary tract infections (UTI).… Read more
-
Strengthening international collaborations with the University of Toronto
A two-day workshop is being held to promote collaborative research opportunities between cancer and inflammation researchers at Hudson Institute and the Department of Immunology at the University of Toronto.… Read more
-
Cancer Council Victoria Postdoctoral Fellowship awarded to progress lung cancer research
Congratulations to Dr Mohamed Saad, who has been awarded a Cancer Council Victoria (CCV) Postdoctoral Cancer Research Fellowship to inform the design of better treatment approaches in lung cancer.… Read more
-
Celebrating a successful Rebecca L Cooper Foundation Grant
Congratulations to Dr Gina Kusuma, who has been awarded a two-year Rebecca L Cooper Medical Research Foundation Project Grant to investigate cell-free therapeutics which can mediate vascular regeneration in the aged population.… Read more
-
Paving the way towards a new anti-inflammatory agent
Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases.… Read more
-
Congratulations to our CASS Foundation grant awardees
Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary aldosteronism and endometriosis in 2020.… Read more
-
Mid-career researcher recognised by the Victorian Cancer Agency
Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).… Read more
-
Protecting growth-restricted babies from brain injury with stem cell therapy
Hudson Institute scientists have demonstrated for the first time that umbilical cord stem cells can protect preterm, growth-restricted babies from brain injury.… Read more
-
Presentation of the inaugural Daniel Wilson Metafit PhD Scholarship
We are pleased to announce that the inaugural recipient of the Daniel Wilson Memorial PhD Scholarship is Alice West—who, thanks to tremendous fundraising efforts, will have her research costs fully covered over the entirety of her 3–4-year study in stomach cancer.… Read more
-
Stem cells help premature babies with lung disease
Hudson Institute and Monash University researchers have assessed the long-term outcomes of their world-first study that used placental stem cells in premature babies with severe bronchopulmonary dysplasia, a form of chronic lung disease.… Read more
Hudson News
Get the inside view on discoveries and patient stories